Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III

NCT05886829 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Symptoms and Signs
COVID-19 Pandemic
Coronavirus Disease 2019
Coronavirus Infections

Interventions

COMBINATION_PRODUCT: Chlorpheniramine Maleate 0.4% Nasal Spray
COMBINATION_PRODUCT: Placebo

Sponsor

Dr. Ferrer BioPharma

Collaborators

[object Object]